Company: HIG-PG
Filing Date: 2025-02-21
Form Type: 10-K
Source: 0000874766-25-000023
Chunk: 854

Company: HARTFORD INSURANCE GROUP, INC.
Filing Date: 2025-02-21
Form: 10-K
Item: Item 12
Chunk 854
---
 assets which are reported in other revenues. For investments accounted for under the equity method, the Company’s maximum exposure to loss as of December 31, 2024 is limited to the total carrying value of $4.6 billion. In addition, the Company has outstanding commitments totaling $2.1 billion to fund limited partnership investments as of December 31, 2024. The Company’s investments accounted for under the equity method are generally of a passive nature in that the Company does not take an active role in the management.For the period ended December 31, 2024, aggregate investment income from investments accounted for under the equity method did not exceed 10% of the Company’s before tax consolidated net income. For the periods ended December 31, 2023 and 2022, aggregate investment income from investments accounted for under the equity method exceeded 10% of the Company’s before tax consolidated net income. Accordingly, the Company is disclosing aggregated, summarized financial data for the Company’s investments accounted for under the equity method based on the most recently available information. This aggregated, summarized financial data does not represent the Company’s proportionate share of investees' assets or earnings.Aggregated summarized financial information of the Company’s equity method investees:As of December 31,20242023Balance sheet:Total assets$356,430 $308,259 Total liabilities$57,017 $44,950 The Company's carrying value$4,552 $4,328 For the years ended December 31,202420232022Operating results:Net investment income (loss)$(1,002)$(1,240)$1,604 Net income excluding net investment income$14,778 $13,000 $11,885 The Company's share of equity method income $103 $181 $533 

156

|Index to Consolidated Financial Statements and SchedulesTable of ContentsNote 6 - DerivativesTHE HARTFORD INSURANCE GROUP, INC.NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

6. DERIVATIVESThe Company utilizes a variety of OTC, OTC-cleared and exchange traded derivative instruments as a part of its overall risk management strategy as well as to enter into replication transactions or income generation covered call transactions. Derivative instruments are used to manage risk associated with interest rate, equity market, commodity market, credit spread, issuer default, price, and currency exchange rate or volatility. Replication transactions are used